Vanda Pharmaceuticals (VNDA) Announces Exclusive License Agreement with Megapharm for Commercialization of Fanapt in Israel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. SPCX
7. AVGO
8. RMAX
9. HD
10. BJ

Go back to Vanda Pharmaceuticals (VNDA) Announces Exclusive License Agreement with Megapharm for Commercialization of Fanapt in Israel
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.28 -0.1 (1.86%)
Previous Close $5.38    52 Week High $18.00 
Open $5.42    52 Week Low $6.91 
Day High $5.42    P/E N/A 
Day Low $5.27    EPS $-0.67 
Volume 656,794